NCT04869137 2026-04-08Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell CarcinomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Active not recruiting26 enrolled 9 charts